|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
|
|---|---|---|---|---|---|---|---|---|---|---|
| Current assets: | ||||||||||
| Cash | ||||||||||
| Short-term prepaid insurance | ||||||||||
| Prepaid expense | ||||||||||
| Cash and cash equivalents | ||||||||||
| Short-term marketable securities | ||||||||||
| Receivables from related parties | ||||||||||
| Prepaid expense and other current assets | ||||||||||
| Prepaid insurance – current portion | ||||||||||
| Total current assets | ||||||||||
| Long-term prepaid insurance | ||||||||||
| Long-term prepaid insurance | ||||||||||
| Marketable securities held in Trust Account | ||||||||||
| Long-term marketable securities | ||||||||||
| Property and equipment, net | ||||||||||
| Operating lease right-of-use asset | ||||||||||
| Other non-current assets | ||||||||||
| Restricted cash | ||||||||||
| Total assets | ||||||||||
| Current liabilities | ||||||||||
| Due to related party | ||||||||||
| Accounts payable and accrued expenses | ||||||||||
| Accounts payable | ||||||||||
| Accrued compensation and benefits | ||||||||||
| Accrued research and development liabilities | ||||||||||
| Accrued professional services | ||||||||||
| Payables to related parties | ||||||||||
| Notes Payable, Current | ||||||||||
| Related Party | ||||||||||
| Total notes Payable, Current | ||||||||||
| Operating lease liability, current | ||||||||||
| Other accrued liabilities | ||||||||||
| Participation right liability | ||||||||||
| Total current liabilities | ||||||||||
| Deferred underwriting fee | ||||||||||
| Operating lease liability, noncurrent | ||||||||||
| Total liabilities | ||||||||||
| Class A ordinary shares subject to possible redemption, 18,400,000 shares at redemption value of $10.68 and $10.46 per share as of June 30, 2025 and December 31, 2024, respectively | ||||||||||
| Class A Ordinary Shares | ||||||||||
| Total class A ordinary shares subject to possible redemption, 18,400,000 shares at redemption value of $10.68 and $10.46 per share as of June 30, 2025 and December 31, 2024, respectively | ||||||||||
| Stockholders' equity (deficit): | ||||||||||
| Preference stock, value | ||||||||||
| Redeemable convertible preferred stock | ||||||||||
| Preferred Stock | ||||||||||
| Common stock, $0.0001 par value; 500,000,000 shares authorized as of June 30, 2026 and December 31, 2025, respectively; 80,088,931 and 79,991,768 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively | ||||||||||
| Class A Ordinary Shares | ||||||||||
| Class B Ordinary Shares | ||||||||||
| Total common stock, $0.0001 par value; 500,000,000 shares authorized as of June 30, 2026 and December 31, 2025, respectively; 80,088,931 and 79,991,768 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively | ||||||||||
| Class B ordinary shares, $0.0001 par value; 50,000,000 shares authorized; 4,600,000 shares issued and outstanding at March 31, 2024 and December 31, 2023 | ||||||||||
| Additional paid-in capital | ||||||||||
| Accumulated deficit | ||||||||||
| Accumulated other comprehensive income (loss) | ||||||||||
| Total stockholders' equity | ||||||||||
| Total liabilities, redeemable convertible preferred stock, and stockholders' equity |
Loading...
